Antag Therapeutics

Denmark
Copenhagen, Capital Region, Denmark, 2200

Company profile

Antag Therapeutics company profile

Antag Therapeutics is a biotechnology company developing metabolic and anti-obesity therapeutic drugs. It offers the development of peptide-based GIP receptor antagonists in order to monitor dietary-related metabolic diseases through the infusion to decrease blood flow and lipid uptake in adipose tissue.

Business identity

Contact email
[email protected]
Phone number
+45 21 45 65 37
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$50,000+
Founded
2017-01-01, Year

Headquarters

Postal code
2200
Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$90.8M
Last funding
Series A / $84.1M / 2024-12-04
Last equity funding
Series A / $84.1M
Investors
10
Lead investors
2
Founders
4
Articles
30

Founders and investors

Founders

Alexander Sparre- UlrichAndreas LaustsenJens Juul HolstMette Marie Rosenkilde

Lead investors

Novo HoldingsVersant Ventures

Investors

Export and Investment FundNovo HoldingsSR OneVaekstfondenVersant Ventures